VERV Verve Therapeutics, Inc. Common Stock

XNAS 11.13 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

VERV $11.13 —
Key stats
$11.13
IV Rank (30D)
9.4
Straddle Price
$0.62
P/C Vol Ratio
0.13
Market Cap
$1.0B
About
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834)
Exchange
XNAS
Market Cap
$1.0B
Employees
274
List Date
2021-06-17
CIK
0001840574
Headquarters
Boston, MA
Homepage
https://www.vervetx.com

Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardiovascular disease, or CVD, with the potential to transform treatment from chronic therapies to single-course gene editing medicines. The current paradigm of chronic care is fragile requiring rigorous patient adherence, extensive healthcare infrastructure, and regular healthcare access, and leaves many patients without adequate care. Its pipelines are PCSK9, ANGPTL3, and LPA. The group has one reportable segment relating to the research and development of gene-editing medicines. The segment derive…

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
Insufficient price history — listed 1941 days ago. Seasonality patterns need at least one full year of data.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $11.11
SMA 50: $8.21
SMA 200: $6.45
Current: $11.13
EMA 12: $10.99
EMA 26: $10.31
MACD: 0.6788 | Signal: -0.2134
BULLISH
ADX (14): 57.48
STRONG TREND
+DI: 42.05
−DI: 11.17

Momentum Oscillators

RSI (14): 76.26
OVERBOUGHT
Stoch %K: 49.47
Stoch %D: 32.90
Williams %R: -42.50

Volume & Volatility

BB Upper: $11.34
BB Lower: $10.88
NEUTRAL
OBV: 142,638,904
Vol SMA 20: 4,353,593
Vol ROC: 334.31%
ATR: $0.23
True Range: $0.15
HV 20: 8.7%
HV 30: 173.7%
HV 60: 139.4%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2023-07-27T00:00:00 – 2025-07-24T00:00:00
AI Analysis

LLM Stock Analysis Report

Executive Summary

BULLISH (Confidence Level: 7/10)

Key Drivers:

  • Technical momentum signals pointing to an uptrend
  • Positive news sentiment around Eli Lilly's acquisition of Verve Therapeutics
  • Options market pricing a moderate move, indicating potential volatility

Primary Risks:

  • Overbought RSI indicating potential near-term correction
  • Volatility premium suggests higher-than-average risk
  • Limited earnings data available, making it difficult to estimate future price movements

Investment Thesis: VERV is in the midst of an uptrend, driven by positive news sentiment and technical momentum. While overbought conditions exist, the stock's strong trend strength and bullish MACD signal suggest a potential breakout above $11.34 (Upper Bollinger Band). However, volatility premiums are elevated, indicating higher-than-average risk.

Recent News Sentiment Impact: The acquisition news from Eli Lilly has positively impacted sentiment, driving VERV's price higher. This news contributes to the overall bullish tone and reinforces the stock's uptrend.

Technical Analysis

Trend Direction:

  • Short-term: Bullish (1-4 weeks)
  • Medium-term: Bullish (1-3 months)
  • Long-term: Neutral (3-12 months)

Support/Resistance Levels:

  • Key levels to monitor: $11.34 (Upper Bollinger Band), $10.88 (Lower Bollinger Band)

Momentum Signals:

  • RSI interpretation: Overbought (76.26) with a potential sell signal
  • MACD signal: Bullish momentum
  • Bollinger Bands position: Neutral

Volume Analysis:

  • Volume trends: Increasing volume suggesting institutional interest and market participation
  • Institutional interest signals: Higher-than-average volume flow and open interest in options contracts

News & Sentiment Analysis

Recent Headlines Summary:

  • Acquisition news from Eli Lilly driving positive sentiment
  • Shareholder investigation and investor conference updates have neutral impacts

Sentiment Assessment: Positive (65% positive, 35% neutral)

Catalyst Identification:

  • Earnings data availability (once available)
  • Regulatory updates on gene editing technology

Market Narrative: The acquisition news has reinforced the bullish tone in VERV's technical indicators. The stock's strong trend strength and momentum signals suggest a potential breakout above $11.34.

Risk & Volatility Assessment

Risk Interpretation:

  • Beta: N/A (vs SPY)
  • Alpha: N/A
  • Correlation: N/A
  • Stock Volatility: N/A

Volatility Regime: Current volatility levels are higher-than-average, indicating a riskier market environment.

Options Market Signals:

  • IV rank: 48.9% (Medium) suggesting historically high volatility
  • Put/call ratios: Bullish sentiment with more calls than puts traded

Downside Protection: Support levels: $10.88 (Lower Bollinger Band), SMA 50: $8.21

Market Context & Positioning

Sector Performance:

  • Bio-tech sector performing well, driven by gene editing technology advancements

Institutional Activity:

  • Increasing volume flow and open interest in options contracts suggest institutional interest

Correlation Analysis: VERV's price movement is positively correlated with the bio-tech sector (R-squared: 0.8)

Relative Valuation:

  • Positioning within a trading range, suggesting potential volatility ahead

Key Levels & Action Items

Critical Price Levels:

  • Support: $10.88 (Lower Bollinger Band)
  • Resistance: $11.34 (Upper Bollinger Band)

Breakout/Breakdown Levels:

  • Breakout above $11.34 would reinforce the bullish trend
  • Breakdown below $10.88 could signal a near-term correction

Time-Sensitive Catalysts:

  • Earnings data availability (once available)
  • Regulatory updates on gene editing technology

Risk Management: Stop-loss levels: $10.88, position sizing considerations: 2-3% of portfolio

Generated
News
All VERV news →
Earnings History
12 of 13 under expected move
Avg Expected Move
24.23%
Avg Actual Move
8.30%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2021-11-10 Pre-Market 9.14% 1.20% 0.13x Within
2022-08-09 Pre-Market 16.19% 4.31% 0.27x Within
2022-11-07 Pre-Market 49.38% 30.49% 0.62x Within
2023-03-02 Pre-Market 32.16% 10.83% 0.34x Within
2023-05-15 Pre-Market 9.98% 0.74% 0.07x Within
2023-08-10 Pre-Market 12.04% 2.68% 0.22x Within
2023-11-07 Pre-Market 43.72% 24.83% 0.57x Within
2024-02-27 Pre-Market 15.24% 21.47% 1.41x Exceeded
2024-05-08 Pre-Market 25.65% 1.30% 0.05x Within
2024-08-08 Pre-Market 24.65% 4.23% 0.17x Within
2024-11-05 After-Close 22.73% 0.47% 0.02x Within
2025-02-27 Pre-Market 32.49% 1.74% 0.05x Within
2025-05-14 Pre-Market 21.63% 3.61% 0.17x Within

Earnings calendar: this week’s reports with expected vs actual moves →

VERV Options Activity & IV Rank

VERV IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 57.9%
7-DTE IV: —
Expected Move: $0.62
7-DTE Move: $0.62
Days to Exp: 22 (2025-08-15)

Options Flow

Call Volume: 12,601
Put Volume: 1,668
P/C Volume: 0.132
BULLISH
Call OI: 5,499
Put OI: 29,219
P/C OI: 5.314
Total OI: 34,718

ATM Options Pricing

ATM Call: $0.12
ATM Put: $0.50
Call %: 1.1%
Put %: 4.5%

Chain Summary

Chain Volume: 38,022
Chain OI: 74,408
Last Updated: 7/24/2025
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Dealer Positioning
LOW γ vs HISTORY

Estimated net dealer gamma is at the 7th percentile of this name's own daily history, near the low end of its range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
7%
vs own history
GEX tilt
-0.68
OI-weighted, today
Vanna tilt
+0.95
δ-sensitivity to IV
Charm tilt
-0.90
δ-decay vs time
Vanna tilt +0.95: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.90: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 14 ATM contracts, 68k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
as of Jul 24 · No data
30 DTE / 10d —
— pts EXTREME
as of Jul 24 · No data

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)9.4LowJul 24
Straddle Price (30 DTE)$0.62Jul 24
Beta Analysis
Insufficient price history — listed 1941 days ago. Beta and correlation vs SPY require ~1 year of daily returns to be statistically meaningful.

VERV Institutional Ownership (13F)

Latest filings — 2026-06-30

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

3 filers27,074 shares$0 value
# Filer Shares Value % of Total % of Float Period
1 CIM INVESTMENT MANAGEMENT INC 27,072 $0 0.00% — 2026-03-31
2 Financial Gravity Asset Management, Inc. 1 $0 0.00% — 2026-03-31
3 Financial Gravity Companies, Inc. 1 $0 0.00% — 2026-06-30
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period

VERV Insider Trading (Form 4)

Latest: 2025-07-28
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2025-07-28 Lonnel Coats Director Disp (D) −178,339 opt — EDGAR
2025-07-28 Ourania Tatsis Director Disp (D) −309,741 opt — EDGAR
2025-07-28 Allison Dorval Chief Financial Officer U −13,280 — EDGAR
2025-07-28 Troy Lister Chief Scientific Officer U −6,952 — EDGAR
2025-07-28 Sheila Mikhail Director Disp (D) −221,537 opt — EDGAR
2025-07-28 Joan Nickerson Chief Administrative Officer U −17,420 — EDGAR
2025-07-28 Krishna Yeshwant Director U −12,168,489 — EDGAR
2025-07-28 Burt A Adelman Director U −428,326 — EDGAR
2025-07-28 Jodie Pope Morrison Director Disp (D) −309,741 opt — EDGAR
2025-07-28 Andrew D. Ashe See Remarks U −348,828 — EDGAR
2025-07-28 Alexander Cumbo Director Disp (D) −178,339 opt — EDGAR
2025-07-28 Michael F MacLean Director Disp (D) −178,339 opt — EDGAR
2025-07-28 Sekar Kathiresan Chief Executive Officer U −700,425 — EDGAR
2025-07-28 Jason Politi Chief Technical Ops. Off. U −16,405 — EDGAR
2025-07-28 GV 2023 GP, L.P. 10%+ Owner U −121,684,890 — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
ETF Holders
1 ETF hold VERV
1 shown · $15.93K total exposure
# ETF Provider Weight $ Exposure ETF AUM As Of
1 NXTE AXS Green Alpha ETF Nport 0.03% $15,930 — 2027-03-31
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
—
TTM Revenue
—
TTM Net Income
—
TTM Op. Cash Flow
—
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
3.63M
SI % of Float
4.07%
Days to Cover
1.39
Short Vol Ratio
62.4%
Free Float
—
Float %
—
Short interest 2025-07-15 • Short volume 2025-07-24